“The Netherlands could become a leader in the field of Value-Based Health Care”, states Harvard Professor Michael Porter. During a working session held in Nijkerk on May 11, key challenges for large-scale implementation of Value-Based Health Care (VBHC) were identified and discussed by twenty-five decision makers in health care from the Netherlands.
This working session was organized by The Decision Group, Amgen and Medtronic to ‘call for action’ and formulate the key actions to collaboratively accelerate VBHC implementation in the Netherlands and improve value for patients.
Are you interested in the final report and/or sharing your thoughts about the Value Agenda?
Please contact us via firstname.lastname@example.org for more information.
Subscribe below to stay up to date on education by The Decision Institute: